Supplemental Information: OLIE, ITCC-082: A phase 2 trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.docx

Name: Supplemental Information: OLIE, ITCC-082: A phase 2 trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.docx
Creator: Taylor & Francis
Published: 2024-05-16 14:22:38
License: 暂无描述

DataCite Commons2024-05-16 更新2025-04-15 收录

下载链接：

https://tandf.figshare.com/articles/dataset/Supplemental_Information_OLIE_ITCC-082_A_phase_2_trial_of_lenvatinib_plus_ifosfamide_and_etoposide_in_relapsed_refractory_osteosarcoma_docx/15156162

下载链接

链接失效反馈

官方服务：

资源简介：

Supplemental Information - Definitions of study endpoints and relevant details

提供机构：

Taylor & Francis

创建时间：

2021-08-12